The U.S. Food and Drug Administration on Friday approved the first treatment for peanut allergy, providing a new option for the growing number of children and their families dealing with the life-threatening condition.
The new treatment, named Palforzia from Aimmune Therapeutics Inc., is designed to work by exposing patients to the very substance they had been taught to avoid. The drug is derived from peanut powder, and doses contain the equivalent of small amounts of peanuts.
Real Life. Real News. Real Voices
Help us tell more of the stories that matterWelcome to NewsGroup
Subscribe to the newsletter news
We hate SPAM and promise to keep your email address safe